Evidence map›Paper›PMID 35163111›Full record

ArticleInternational journal of molecular sciences2022

Fentanyl but Not Morphine or Buprenorphine Improves the Severity of Necrotizing Acute Pancreatitis in Rats.

Emese Réka Bálint, Gabriella Fűr, Balázs Kui, Zsolt Balla, Eszter Sára Kormányos, Erik Márk Orján, Brigitta Tóth, Gyöngyi Horváth, Edina Szűcs, Sándor Benyhe and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Emese Réka BálintDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.
Gabriella FűrDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.
Balázs KuiDepartment of Medicine, University of Szeged, 6725 Szeged, Hungary.
Zsolt BallaDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.
Eszter Sára KormányosDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.ORCID 0000-0002-6201-1341
Erik Márk OrjánDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.
Brigitta TóthDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.
Gyöngyi HorváthDepartment of Physiology, University of Szeged, 6725 Szeged, Hungary.ORCID 0000-0002-6025-4577
Edina SzűcsInstitute of Biochemistry, Biological Research Center, 6726 Szeged, Hungary.
Sándor BenyheInstitute of Biochemistry, Biological Research Center, 6726 Szeged, Hungary.
Eszter DuczaDepartment of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.
Petra PallagiDepartment of Medicine, University of Szeged, 6725 Szeged, Hungary.ORCID 0000-0001-8906-0840
József MaléthDepartment of Medicine, University of Szeged, 6725 Szeged, Hungary.ORCID 0000-0001-5768-3090
Viktória VengloveczDepartment of Pharmacology and Pharmacotherapy, University of Szeged, 6725 Szeged, Hungary.
Péter HegyiDepartment of Medicine, University of Szeged, 6725 Szeged, Hungary.
Lóránd KissDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.
Zoltán RakonczayDepartment of Pathophysiology, University of Szeged, 6725 Szeged, Hungary.ORCID 0000-0002-1499-3416
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HU

Funding

European Union EFOP-3.6.2-16-2017-00006European Union GINOP-2.3.2-15-2016-00048Hungarian Academy of Sciences Bólyai János Research Grant (BO/00866/20/5)Hungary NKFIH K119938Hungary NKFIH PD129114University of Szeged ÚNKP Grant (ÚNKP-20-5 -SZTE-163)
6 · The paper itself

Abstract

Opioids are widely used for the pain management of acute pancreatitis (AP), but their impact on disease progression is unclear. Therefore, our aim was to study the effects of clinically relevant opioids on the severity of experimental AP. Various doses of fentanyl, morphine, or buprenorphine were administered as pre- and/or post-treatments in rats. Necrotizing AP was induced by the intraperitoneal injection of L-ornithine-HCl or intra-ductal injection of Na-taurocholate, while intraperitoneal caerulein administration caused edematous AP. Disease severity was determined by laboratory and histological measurements. Mu opioid receptor (MOR) expression and function was assessed in control and AP animals. MOR was expressed in both the pancreas and brain. The pancreatic expression and function of MOR were reduced in AP. Fentanyl post-treatment reduced necrotizing AP severity, whereas pre-treatment exacerbated it. Fentanyl did not affect the outcome of edematous AP. Morphine decreased vacuolization in edematous AP, while buprenorphine pre-treatment increased pancreatic edema during AP. The overall effects of morphine on disease severity were negligible. In conclusion, the type, dosing, administration route, and timing of opioid treatment can influence the effects of opioids on AP severity. Fentanyl post-treatment proved to be beneficial in AP. Clinical studies are needed to determine which opioids are best in AP.

Indexed as

Severity of Illness IndexAnalgesics, OpioidAnimalsBuprenorphineFemaleFentanylMorphinePancreatitis, Acute NecrotizingRatsRats, WistarReceptors, Opioid, muAnalgesics, OpioidBuprenorphineFentanylMorphineReceptors, Opioid, muacute pancreatitisanalgesiabuprenorphinefentanylmorphineopioids

Identifiers

PMID35163111
PMCPMC8835441
OpenAlexW4207028332

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.